Skip to main content
SIBN
NASDAQ Industrial Applications And Services

SI-BONE Exceeds Q1 Estimates, Raises 2026 Guidance, and Highlights Positive CMS Proposal

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$12.75
Mkt Cap
$513.67M
52W Low
$11.48
52W High
$21.89
52W Position info
11% above low
Off High info
42% below high
Rel. Volume info
2.6× avg
Market data snapshot near publication time

SIBN is trading near its 52-week low of $11.48 (11% above the low) on elevated volume (2.6× avg).

Summary

SI-BONE, Inc. reported strong first-quarter 2026 financial results, surpassing revenue estimates and significantly improving profitability, while also raising its full-year 2026 guidance and highlighting a favorable CMS proposal for its procedures.


Key Events · Earnings and Guidance · SIBN

  • Strong Q1 Performance

    Worldwide revenue reached $52.6 million, exceeding analyst estimates and representing an 11.2% increase year-over-year.

  • Significant Profitability Improvement

    Net loss improved by 33.8% to $4.3 million, and Adjusted EBITDA surged over 440% to $2.5 million, demonstrating enhanced operational efficiency.

  • Raised Full-Year Guidance

    The company increased its 2026 worldwide revenue expectation to a range of $230 million to $233 million and raised its gross margin estimate to approximately 79%.

  • Favorable CMS Proposal

    CMS proposed a new MS-DRG family with higher payment for complex spinal fusion procedures incorporating iFuse Bedrock Granite, a key product, which could significantly impact future reimbursement.


Analysis · SIBN · Industrial Applications And Services

This filing is highly important because SI-BONE not only delivered strong first-quarter results, beating revenue estimates and showing substantial improvement in profitability, but also raised its full-year financial guidance. Crucially, the positive CMS proposal for higher reimbursement for its key procedures could significantly boost future adoption and revenue, providing a strong long-term tailwind for the company.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SIBN was trading at $12.75 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $513.7M. The 52-week trading range was $11.48 to $21.89. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SIBN - Latest Insights

SIBN
Nov 03, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $23.77
Real-time Price: $23.81 info
Change: +$0.040 (+0.17%) info
Market Cap: $1.075B info
SIBN
Nov 02, 2026, 4:09 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $20.63
Real-time Price: $23.81 info
Change: +$3.18 (+15%) info
Market Cap: $1.075B info
SIBN
Sep 28, 2026, 4:09 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $19.14
Real-time Price: $23.81 info
Change: +$4.67 (+24%) info
Market Cap: $1.075B info
SIBN
Sep 11, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.39
Real-time Price: $23.81 info
Change: +$4.42 (+23%) info
Market Cap: $1.075B info
SIBN
Aug 04, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $18.44
Real-time Price: $23.81 info
Change: +$5.37 (+29%) info
Market Cap: $1.075B info